Request a video call

Select time

Select date

Select time

Select Time zone

Profile
Details
Treatments
Qualifications
Testimonials
Awards
Destination

Jiahui International Hospital | CAR-T Cell Therapy in China Profile Overview

CAR-T Cell Therapy Center at Jiahui International Hospital Shanghai China

Jiahui International Hospital: Premier CAR-T Cell Therapy Center in China

Advanced CAR-T Cell Therapy in Shanghai China

At Jiahui International Hospital, we are dedicated to offering cancer patients a powerful new path toward remission through state-of-the-art oncology care and cellular immunotherapy. As an internationally recognized CAR-T Cell Therapy in Shanghai China, our center delivers world-class medical excellence within a patient-centered model. We bring together advanced global protocols and top-tier clinical expertise to fight complex blood cancers. Every treatment program is precisely personalized to the patient’s medical history, genetic profile, and overall health to optimize efficacy and safety.

World-Class Hematological Oncology & Target Immunotherapies

For patients navigating complex hematological malignancies, our specialized oncology department provides highly targeted, next-generation medical interventions. By introducing advanced Leukemia Treatment in China and customized Lymphoma CAR-T Therapy in China, we harness the power of your body’s own immune system to identify and destroy malignant cancer cells. Our multidisciplinary team conducts rigorous baseline evaluations and utilizes high-standard cellular processing to offer life-saving alternatives where traditional chemotherapy or stem cell transplants may have fallen short.

Advanced CAR-T Cell Therapy Laboratory Jiahui Health Shanghai

A Dedicated Focus on Multiple Myeloma & Cellular Engineering

Beyond leukemia and lymphoma, Jiahui Health is at the forefront of treating plasma cell disorders. We are proud to provide cutting-edge Multiple Myeloma Immunotherapy in China, utilizing specific chimeric antigen receptors designed to seek out and eradicate myeloma cells. By utilizing highly specialized and internationally monitored laboratory procedures, our physicians are equipped to treat refractory cases, helping international and domestic patients achieve deep, long-term clinical responses while significantly improving their long-term survival and quality of life.

Key Takeaways:

Advanced Immunotherapy Focus: Specialized exclusively in cutting-edge CAR-T cell engineering for leukemia, lymphoma, and multiple myeloma.
International Care Standards: Strategic collaboration with Massachusetts General Hospital brings global clinical protocols to our medical team in Shanghai.
Elite JCI Accreditation: As Shanghai’s first government-authorized international hospital, Jiahui strictly adheres to Joint Commission International safety standards.
Multidisciplinary Care Team: Over 25% of our physicians are recruited internationally, working in close collaboration with leading Chinese oncology specialists.
Comprehensive Patient Support: Offering bilingual services, dedicated international patient coordinators, and modern post-therapy monitoring.

Did You Know?

Jiahui International Hospital in Shanghai was founded in 2017 as the city’s flagship international-standard medical institution. It features a modern 500-bed facility designed to deliver seamless, top-tier healthcare services, integrating international oncology benchmarks directly into China’s rapidly advancing biotech landscape.

Specialized CAR-T Solutions and Therapy Management

Patient safety, regulatory rigor, and evidence-based oncology remain at the heart of our mission. Jiahui Health leverages its elite healthcare network to ensure that every phase of your cellular processing and infusion aligns perfectly with the highest clinical standards.

Precision Cellular Processing & Target Applications

Reprogramming a patient's T-cells to aggressively target and eliminate cancer requires absolute precision. Our clinic utilizes advanced medical frameworks to address different hematological conditions:

Treatment Category	Clinical Application	Patient Goals
Leukemia CAR-T Therapy	Targeting CD19/CD22 antigens in refractory or relapsed Acute Lymphoblastic Leukemia (ALL).	Achieving complete molecular remission, supporting immune system recovery, and preventing recurrence.
Lymphoma CAR-T Therapy	Engineered cellular targeting for Large B-cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma.	Rapid tumor reduction, long-term disease-free survival, and localized lesion management.
Multiple Myeloma Immunotherapy	B-cell maturation antigen (BCMA) targeted cell therapy for relapsed plasma cell cancer.	Sustained control of bone marrow disease, lowering M-protein levels, and organ preservation.

Global Scientific Collaborations and Targeted Clinical Scope

Unlike standard regional clinics, Jiahui Health has established a comprehensive oncology program built on international partnerships. Through our collaboration with Massachusetts General Hospital, we maintain a direct line to cutting-edge scientific updates, clinical trial insights, and expert medical second opinions. By maintaining our medical protocols strictly focused on advanced hematological oncology, we ensure our patients receive the most current, validated, and ethically sound therapies available globally.

Core Specialization and Health Services

As the definitive center for CAR-T Cell Therapy in Shanghai China, we provide a broad range of high-level oncology services:

Comprehensive Diagnostic Screening and Molecular Profiling for Hematological Cancers
Advanced Autologous T-Cell Collection (Apheresis) under strict sterile conditions
High-Fidelity Genetic Modification and Expansion of CAR-T Cells
Targeted Pre-Infusion Lymphodepleting Conditioning (Chemotherapy Prep)
State-of-the-Art Inpatient CAR-T Cell Infusion and Monitoring
Dedicated Intensive Care and Managing Cytokine Release Syndrome (CRS) protocols
Certified Laboratory Standards aligned with international GMP and JCI criteria
Multidisciplinary Oncology Board reviews featuring international medical experts
Bilingual Patient Coordination, Medical Translation, and Post-Discharge Follow-up Care

Why Choose Shanghai, China for CAR-T Cell Therapy?

A Global Hub for Biotech and Cellular Immunotherapy

Seeking cancer treatment abroad requires absolute trust in both the destination and the medical infrastructure. Shanghai stands as one of the most technologically advanced medical hubs in the world, leading the industry in CAR-T clinical trials, biotechnology research, and rapid approvals for breakthrough cellular therapies. This allows patients to access highly modern, approved cellular protocols that may not yet be available or affordable in their home countries.

Modern Infrastructure and Exceptional Global Connectivity

As a key international metropolis, Shanghai offers effortless travel logistics for patients arriving from North America, Europe, Southeast Asia, and beyond. With two major international airports, premier bullet train networks, and a world-class hospitality sector, the city minimizes travel-related stress. Jiahui International Hospital is centrally located, offering patients and their families secure, luxury-adjacent accommodations, bilingual city services, and a serene healing environment.

Fast Facts about Shanghai Medical Tourism and Oncology:

Government-Backed Quality: China’s National Medical Products Administration (NMPA) maintains strict safety and efficacy guidelines for all approved cellular therapies.
World-Class Airports: Daily direct flights connect Pudong (PVG) and Hongqiao (SHA) airports with major international transit hubs globally.
Advanced Oncology Integration: Highly efficient translation from lab to clinic, meaning shorter wait times for qualifying patients.
Excellent Cost-Value Balance: Accessing top-tier, international-standard CAR-T therapy at a fraction of Western hospital costs.

Why Choose Jiahui International Hospital for Your Oncology Care?

✓ Massachusetts General Hospital Collaboration: Benefit from medical protocols developed alongside one of the top oncology institutions in the United States.

✓ Elite JCI Accreditation: Our hospital strictly complies with gold-standard international patient safety and healthcare quality policies.

✓ Tailored Cellular Therapeutics: No standardized oncology plans; every cell engineering protocol is designed for your specific cancer markers.

✓ 24/7 Multi-Specialty Support: On-site access to intensive care, cardiology, emergency medicine, and supportive care during your recovery.

✓ International Patient Services: Fully integrated bilingual staff, visa assistance, and specialized medical liaison coordinators to guide you every step of the way.

Frequently Asked Questions (FAQs)

1. What types of cancers are treated at Jiahui’s CAR-T Cell Therapy Center?

Our center specializes in treating hematological malignancies, including relapsed or refractory Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL), and Multiple Myeloma.

2. How does the collaboration with Massachusetts General Hospital impact my CAR-T therapy?

It ensures that your diagnostic profiles, treatment planning, and safety protocols align with world-leading oncology practices, giving you access to international clinical wisdom right here in Shanghai.

3. Am I an eligible candidate for CAR-T cell therapy in China?

Eligibility is determined on an individual basis. Our medical board conducts a comprehensive review of your pathological files, previous chemotherapy history, and current organ function to safely confirm eligibility.

4. How long is the treatment process for CAR-T therapy at Jiahui International Hospital?

The total timeline typically ranges from 4 to 6 weeks. This includes the initial T-cell collection (apheresis), 2-4 weeks of laboratory cell modification, a short conditioning chemotherapy, and post-infusion monitoring.

5. How does Jiahui manage side effects such as Cytokine Release Syndrome (CRS)?

As a JCI-accredited, full-scale hospital, we have on-site, state-of-the-art ICU facilities, specialized critical care physicians, and stocked therapeutic countermeasures (like Tocilizumab) to manage CRS safely and immediately.

6. Can international patients receive CAR-T cell therapy at your clinic?

Yes. Jiahui Health is fully equipped to serve international patients. We provide multilingual support, translation of medical records, and specialized assistance for medical visas and accommodations.

7. Is the medical and nursing staff at Jiahui International Hospital bilingual?

Yes, our oncology team and international patient service coordinators communicate fluently in English and Mandarin, ensuring clear, accurate, and comfortable communication during your treatment.

8. Are cellular therapy laboratories in China strictly regulated?

Absolutely. All cellular manufacturing and handling are performed in certified laboratories that comply with China’s National Medical Products Administration (NMPA) standards and strict international GMP guidelines.

9. What diagnostic files should I provide for a virtual pre-evaluation?

To begin your pre-evaluation, you will need to submit your complete medical records, recent bone marrow biopsy results, blood work, PET-CT scans, and details of all prior oncology treatments.

10. How do I initiate my medical travel consultation for CAR-T therapy?

You can securely contact Jiahui International Hospital and submit your clinical records through the PlacidWay Medical Tourism platform, where an international case manager will guide you through the process step-by-step.

Take the Next Step Toward Cellular Recovery and Remission

Empower your fight against hematological cancer by exploring the future of personalized oncology. Schedule a clinical evaluation at Jiahui International Hospital, a leading center for CAR-T Cell Therapy in Shanghai China, through PlacidWay Medical Tourism.

PlacidWay connects you directly with premier, verified international healthcare networks. By arranging your consultation through our platform, you benefit from:

JCI-Accredited Safety

Mass General Collaboration

Elite Shanghai Biotech Hub

Your journey toward advanced cancer care, world-class cellular engineering, and professional medical guidance is backed by rigorous clinical excellence and international safety standards in Shanghai, China.

Contact PlacidWay for a Free CAR-T Therapy Quote

Jiahui International Hospital | CAR-T Cell Therapy in China, Shanghai, China Profile Details

International CAR-T Cell Therapy Center in China by Jiahui Hospital

Jiahui International Hospital stands as a premier medical institution in Shanghai, China, dedicated to clinical excellence, patient-centric safety, and cutting-edge oncological solutions. As a leading Leukemia Treatment in China, our international-standard medical center provides a highly specialized, dedicated pathway for Chimeric Antigen Receptor T-cell (CAR-T) therapy. This program is designed to manage the complex, end-to-end requirements of this revolutionary immunotherapy, ensuring that global and local patients receive elite care within a secure, state-of-the-art environment.

By choosing Jiahui International Hospital, patients gain access to a fully integrated healthcare ecosystem where clinical expertise meets the latest innovations in cellular immunotherapy. Our comprehensive oncology and hematology divisions ensure that every individual undergoing CAR-T Cell Therapy in Shanghai China receives a treatment plan tailored specifically to their biological profile. We combine rigorous international protocols with highly specialized care to deliver elite medical services for complex blood cancers.

CAR-T Cell Therapy in China

Why Jiahui International Hospital is a Top Choice for Patient Care:

International Standards: A world-class, multi-specialty hospital operating in collaboration with global healthcare leaders to deliver top-tier safety and clinical protocols.
Comprehensive End-to-End Care: Seamless management of the entire CAR-T journey—from precise apheresis (cell collection) and specialized laboratory coordination to targeted infusion and ICU-level monitoring.
Multidisciplinary Specialist Teams: Lead by internationally trained, board-certified hematologists, oncologists, and intensive care specialists who specialize in managing cellular therapy and potential immune responses.
State-of-the-Art Facilities: Equipped with dedicated oncology wards, advanced laminar flow cleanrooms, and fully integrated diagnostic centers right in the heart of Shanghai.
Approved Cellular Protocols: Offering established, clinically validated CAR-T formulations alongside access to cutting-edge clinical research platforms.

What Makes Our CAR-T Hematology & Oncology Programs Stand Out?

At Jiahui International Hospital, our commitment to clinical transparency and patient safety defines our reputation as a trusted center. We believe that successful outcomes in immunotherapy are achieved through strict coordination, advanced laboratory quality controls, and customized treatment mapping. By maintaining a highly structured clinical evaluation process—incorporating comprehensive bone marrow biopsies, advanced imaging, and systemic fitness evaluations—we deliver unmatched safety and efficacy.

Core Therapeutic Area	Our Clinical Approach
Leukemia Treatment in China	Targeting B-cell Acute Lymphoblastic Leukemia (B-ALL) and relapsed/refractory variations with highly precise, patient-specific receptor modification.
Lymphoma CAR-T Therapy in China	Managing complex cases including Diffuse Large B-Cell Lymphoma (DLBCL), High-Grade Lymphoma, Mantle Cell Lymphoma, and Follicular Lymphoma.
Multiple Myeloma Immunotherapy in China	Administering highly optimized CAR-T targets designed specifically to address relapsed or refractory multiple myeloma, helping achieve durable remission.

Clinical Focus: Jiahui International Hospital specializes in navigating the complex phases of CAR-T cell manufacturing and clinical monitoring. Our intensive care and oncology wards are specially staffed to manage Cytokine Release Syndrome (CRS) and neurological toxicities, ensuring complete safety at every phase of recovery.

Who is a Suitable Candidate for CAR-T Cell Therapy?

Our international center for CAR-T Cell Therapy in Shanghai China is a key destination for individuals seeking advanced options for relapsed or refractory hematological malignancies. We welcome domestic and international patients from around the globe who require high-precision medical care in an accessible, ultra-modern metropolis.

Established Blood Cancers

Patients diagnosed with B-cell acute lymphoblastic leukemia (B-ALL), chronic lymphocytic leukemia (CLL), or refractory lymphomas who have not responded to conventional chemotherapy regimens.

Multiple Myeloma Patients

Individuals with relapsed or refractory multiple myeloma who require advanced immunotherapeutic intervention following multiple lines of standard systemic treatment.

Emerging & Investigational Cases

Patients seeking clinical trials for solid tumors (such as lung, liver, gastric, or pancreatic cancers), autoimmune diseases (such as Lupus/SLE, Scleroderma, or MS), or complex myeloid disorders.

Our hospital stands out as an elite medical destination that prioritizes scientific integrity, absolute safety, and patient comfort. Whether you are seeking treatment for a primary indication or exploring clinical research protocols, our multidisciplinary team of international specialists is dedicated to providing world-class medical care in a secure and supportive environment.

Begin Your Precision Treatment Journey in Shanghai!

Take the next step in your medical recovery with advanced CAR-T therapy protocols at Jiahui International Hospital by connecting with our dedicated international team through PlacidWay Medical Tourism.

Jiahui International Hospital | CAR-T Cell Therapy in China Treatments Offered

Comprehensive Oncology Care and Procedures in Shanghai

Are you seeking the pinnacle of medical innovation for fighting complex blood cancers? Jiahui International Hospital stands as a premier destination and leading CAR-T Cell Therapy Clinic in China, dedicated to the highest standards of cellular immunotherapy. We offer highly sophisticated, personalized treatments, establishing our facility as a top choice for patients requiring advanced CAR-T Cell Therapy in Shanghai China. Our international hospital serves as a state-of-the-art medical hub, ensuring every patient receives an expert, results-oriented experience in one of Shanghai's most prestigious and modern medical districts.

At Jiahui International Hospital, our medical focus is strictly on therapeutic precision, patient safety, and long-term remission. Whether you are seeking cutting-edge Leukemia Treatment in China or a targeted, clinically advanced Lymphoma CAR-T Therapy in China, our multidisciplinary team of oncologists, hematologists, and intensive care specialists deliver world-class clinical care. By leveraging refined genetic engineering and patient-specific cellular sciences, we provide revolutionary therapies that empower your own immune system to target and destroy cancer cells.

CAR-T Cell Therapy in Shanghai China at Jiahui International Hospital

Key Clinic Highlights:

Oncology Excellence: Specialized hematologic cancer programs using high-viability, genetically modified T cells designed to specifically recognize and eliminate malignant tumor cells.
Cellular Precision: Tailored therapies utilizing advanced antigen-targeting mechanisms (such as CD19 and BCMA) to optimize treatment response and protect healthy tissue.
Multidisciplinary Care: Seamless integration between laboratory scientists, clinical hematologists, and specialized ICU teams to ensure safe monitoring of cellular infusion side effects.
International Standards: A world-class clinical infrastructure operating under strict global healthcare protocols, catering to both domestic and international patients in Shanghai.
Personalized Design: Comprehensive pre-treatment staging, rigorous patient suitability assessments, and customized post-infusion recovery tracking designed for every individual.

Did You Know?

CAR-T cell therapy is often referred to as a "living drug." At Jiahui International Hospital, we extract a patient's own T cells, genetically reprogram them in a specialized laboratory to identify tumor-specific markers, and multiply them into millions before infusing them back to systematically target cancer cells.

Comprehensive Immunotherapy & Focused Hematology Services

Our facility provides an extensive array of biological procedures designed to treat complex blood cancers, offering hope through the most innovative Multiple Myeloma Immunotherapy in China and targeted leukemia and lymphoma programs.

Targeted Leukemia Immunotherapies

CAR-T Cell Therapy for Acute Lymphoblastic Leukemia (ALL): Uses engineered T cells to target and eliminate leukemia cells in patients with relapsed or refractory B-cell ALL.
CAR-T Cell Therapy for Acute Myeloid Leukemia (AML): Available through clinical evaluation for selected patients with relapsed or treatment-resistant acute myeloid leukemia.
CAR-T Cell Therapy for Chronic Lymphocytic Leukemia (CLL): Treats advanced or relapsed CLL by reprogramming immune cells to attack cancer cells.

Advanced Lymphoma CAR-T Solutions

CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): An advanced treatment option for patients whose lymphoma has relapsed or failed previous therapies.
CAR-T Cell Therapy for B-Cell Lymphoma: Targets CD19-positive B-cell lymphomas, including aggressive and relapsed forms.
CAR-T Cell Therapy for Follicular Lymphoma: Provides a personalized immunotherapy option for relapsed or refractory follicular lymphoma.
CAR-T Cell Therapy for Mantle Cell Lymphoma: Offers a targeted treatment for patients with recurrent or treatment-resistant mantle cell lymphoma.

Myeloma, MDS & Relapsed/Refractory Care

CAR-T Cell Therapy for Multiple Myeloma: Uses BCMA-targeted CAR-T cells to treat relapsed or refractory multiple myeloma after prior therapies.
CAR-T Cell Therapy for Myelodysplastic Syndrome (MDS): Evaluated as part of advanced hematologic cancer management in selected patients.
CAR-T Cell Therapy for Relapsed or Refractory Hematologic Malignancies: Designed for patients with blood cancers that have not responded to standard chemotherapy, targeted therapy, or stem cell transplantation.

Our Specialized Clinical Services Include:

Precision Tumor Antigens: Advanced matching protocols targeting specific cancer cell antigens to optimize the cellular payload's accuracy and impact.
Robust Patient Pre-Conditioning: Specialized low-dose chemotherapy plans to prepare the patient's immune system prior to receiving CAR-T cell infusions.
Advanced Toxicity Management: Proactive clinical safety frameworks engineered to rapidly diagnose and treat Cytokine Release Syndrome (CRS) and neurotoxicity.
In-Depth Clinical Consultations: Highly comprehensive clinical assessments mapping out your exact oncological medical history before initiating cellular harvesting.

Unlock Your Treatment Potential Today

Consult with the leading experts in advanced immunotherapy and cellular oncology at Jiahui International Hospital. Whether you are exploring alternative treatments for relapsed blood cancers or seeking an advanced personalized clinical evaluation, our medical team is prepared to assist you. Contact us through PlacidWay Medical Tourism to explore your options for premier CAR-T cell therapies in Shanghai, China, and start your customized journey toward cellular recovery.

Request a Free Quote

Jiahui International Hospital | CAR-T Cell Therapy in China Certificates, Accreditations, Qualifications Treatments Offered

Top Specialists at CAR-T Cell Therapy Center in Shanghai, China

At Jiahui International Hospital, we offer world-class oncology and hematology care, standing as a premier destination for CAR-T Cell Therapy in Shanghai China. Our state-of-the-art facility is committed to delivering highly advanced immunotherapies, bringing together international clinical protocols, modern medical infrastructure, and an experienced multidisciplinary team to offer patient-centric, life-saving solutions for complex hematologic cancers.

For patients seeking effective Lymphoma CAR-T Therapy in China, our center utilizes the latest modifications in genetically engineered immune cells to precisely target and eliminate cancer cells. Jiahui International Hospital serves as a distinguished CAR-T Cell Therapy Clinic in China, providing customized therapeutic pathways that adhere strictly to global safety and quality standards, helping international patients access groundbreaking options for blood-borne malignancies.

Advanced Clinical Focus: Leukemia, Lymphoma, and Multiple Myeloma

Our clinical foundation is focused on providing targeted immune-oncology interventions to combat treatment-resistant blood cancers. By isolating, genetically engineering, and reinfusing a patient’s own T-cells, our therapies are specifically calibrated to hunt down and eradicate malignant cells. This sophisticated biological approach provides a powerful pathway for patients requiring advanced cellular care.

CAR-T Cell Therapy in Shanghai China: State-of-the-art laboratory engineering and clinical execution of personalized immune treatments.
Leukemia Treatment in China: Targeted genetic protocols engineered to fight acute and chronic leukemic strains.
Lymphoma CAR-T Therapy in China: Cutting-edge treatments designed to combat refractory and relapsed non-Hodgkin and Hodgkin lymphomas.
Multiple Myeloma Immunotherapy in China: Novel cellular pathways targeting specific myeloma markers to promote deep, sustained clinical remission.

Jiahui International Hospital: Leading CAR-T Cell Doctors in China

Our Comprehensive Medical Team

A defining feature of Jiahui International Hospital is our dedicated network of internationally trained clinical hematologists, oncologists, and transplant experts who ensure absolute patient safety throughout the cellular collection, preparation, and infusion processes.

Prof. HAO Siguo, MD, PhD

Prof. HAO Siguo, MD, PhD - Hematology & CAR-T Therapy Specialist

Prof. HAO Siguo is an esteemed Hematology expert specializing in leukemia, lymphoma, and multiple myeloma. With deep proficiency in hematopoietic stem cell transplantation (HSCT) and advanced CAR-T cell therapy, he leads the development of highly customized cellular immunotherapy protocols for complex blood cancers at Jiahui International Hospital.

Dr. XU Rong, MD

Dr. XU Rong, MD - Hematology & CAR-T Therapy Specialist

Dr. XU Rong is a highly accomplished Hematology specialist focused on leukemia, lymphoma, multiple myeloma, and hematopoietic stem cell transplantation (HSCT). She combines state-of-the-art CAR-T therapy protocols with precise intensive care management to support patients through every critical phase of blood cancer treatment.

Dr. XUAN Linli, MD - Medical Oncology & Hematology Specialist

Dr. XUAN Linli is a skilled oncologist and hematologist with extensive experience treating leukemia, lymphoma, and multiple myeloma. Her multidisciplinary approach integrates cancer genetics, palliative care, and state-of-the-art CAR-T cell therapy to provide holistic, targeted treatment regimens for oncology patients.

Service Category	Key Clinical Expertise
Lymphoma CAR-T Therapy in China	Advanced clinical targeting and modification of T-cells to combat aggressive, resistant, and relapsed lymphomas.
Leukemia Treatment in China	Comprehensive cellular protocols, high-precision immunotherapies, and stem cell transplantation for leukemic patients.
Multiple Myeloma Immunotherapy in China	Novel CAR-T options targeting BCMA and other myeloma-specific antigens to achieve deep clinical molecular remission.

By bringing together world-class clinical research, rigorous laboratory engineering, and international safety protocols, the oncology team at Jiahui International Hospital delivers compassionate, advanced care. When searching for reliable, internationally accredited pathways for blood cancer treatments, you can rely on our clinic for transparent and scientifically sound medical care.

Fight Blood Cancer with Certified Immunotherapy Experts

The specialized medical team at Jiahui International Hospital is ready to provide the most innovative options in CAR-T Cell Therapy in Shanghai China, giving patients a renewed pathway toward remission.

Take the First Step Toward Advanced Healing!

Discover how the latest breakthroughs in CAR-T Cell Therapy in Shanghai China can transform your treatment outcomes. Book your personalized consultation today at the leading CAR-T Cell Therapy Clinic in China through PlacidWay Medical Tourism.

Jiahui International Hospital | CAR-T Cell Therapy in China Testimonials

Real Patient Experiences at Jiahui International Hospital in Shanghai

Shanghai has established itself as a premier global hub for medical innovation, particularly in advanced oncology and cellular therapies. As a leading CAR-T Cell Therapy Clinic in China, Jiahui International Hospital offers international and local patients state-of-the-art immunotherapy protocols designed to target hard-to-treat hematological malignancies. Through specialized clinical pathways, this world-class medical center provides hope and cutting-edge options for patients seeking clinical remission.

When considering options for highly advanced CAR-T Cell Therapy in Shanghai China, hearing from patients who have walked this path is invaluable. Jiahui International Hospital focuses on delivering personalized care, offering comprehensive services including targeted Leukemia Treatment in China, specialized Lymphoma CAR-T Therapy in China, and revolutionary Multiple Myeloma Immunotherapy in China. Managed by an expert, multidisciplinary clinical team, the entire protocol is backed by internationally accredited safety standards and fully equipped ICU support.

Jiahui International Hospital CAR-T Cell Therapy Shanghai China

Real Stories: Hope & Healing with CAR-T Therapy in China

“My entire treatment journey at Jiahui has been smooth throughout. I've had really good support from the medical team—from my doctors through to the nursing team. It's been a good experience. I have been able to work right through the whole treatment. It's only in the last three weeks that I've had to take any time off, so it has been really smooth being able to combine treatment with my working life here. While every patient is different, my side effects were ok and I know Jiahui's team watched me really closely, so it's been a real bonus during the last few weeks.”

- Unnamed Foreign Patient (Shanghai Resident)

Verified Patient | Multiple Myeloma treated with CAR-T

“The entire treatment process at Jiahui was very professional, and I received meticulous care. The nursing team, in particular, looked after me like a family member. The medical service here is world-class. Diagnostic imaging was completed quickly, with most reports available the next day.”

- 78-year-old Retired Family Physician (New Zealand)

Verified Patient | Relapsed Multiple Myeloma treated with CAR-T

“When treatment was no longer working in Pakistan, the doctors told me I would need to go abroad. Jiahui responded quickly and helped guide us through the process, especially the medical visa application and logistical arrangements. We are Muslims, so we asked the staff, 'Please provide us with Muslim food.' They prepared food according to our needs and preferences. Chinese people are very cooperative. The doctors, nurses, and staff were very supportive.”

- Muhammad (Pakistan)

Verified Patient | Stage IVB Diffuse Large B-Cell Lymphoma (CAR-T)

“When I was seriously ill during lockdown and felt like I was almost dying, I knew I needed a comprehensive medical center with ICU care, so I chose Jiahui.”

- Ms. Lyn She

Verified Patient | First CAR-T Patient at Jiahui

Verified Clinical Statistics

The commitment of Jiahui International Hospital to cutting-edge hematology care and clinical safety is reflected in our exceptional service standards:

24/7

Full ICU & Emergency Support

Next-Day

Average Imaging Diagnostics Delivery

100%

Tailored Dietary & Logistical Support

Why Choose Jiahui International Hospital for CAR-T Cell Therapy?

The feedback from our global patient community highlights why Jiahui is the preferred facility for advanced immunotherapy. Patients consistently praise our international medical team for their ability to manage complex cases of hematological malignancies with extraordinary precision, safety, and cultural empathy. By providing robust support—from visa facilitation and customized dietary arrangements to close side-effect monitoring—Jiahui delivers comprehensive clinical outcomes with a deeply human touch.

Whether navigating relapsed multiple myeloma, advanced lymphoma, or looking for leading oncology expertise, these clinical testimonials confirm an elite standard of international healthcare. For patients seeking medical travel options, Jiahui International Hospital in Shanghai provides a secure, modern, and compassionate environment where difficult diagnoses are met with leading-edge medical solutions.

Are you ready to explore advanced cellular treatment options? Join patients from across the globe who have placed their trust in Jiahui's world-class medical expertise, advanced intensive care infrastructure, and life-changing immunotherapy treatments.

Take the First Step Toward Advanced CAR-T Therapy in Shanghai

Consult with the oncology and immunotherapy specialists at China's premier international clinical center. Contact Jiahui International Hospital through PlacidWay Medical Tourism today to explore your customized clinical pathway.

Contact PlacidWay for a Free Quote

Jiahui International Hospital | CAR-T Cell Therapy in China Awards & Recognitions

World-Class Standards in Chinese Oncology & Cellular Immunotherapy

Jiahui International Hospital stands as a premier CAR-T Cell Therapy Clinic in China, dedicated to delivering world-class cellular therapies backed by verifiable clinical achievements. Located in the highly modern medical hub of Shanghai, our elite medical team specializes in advanced protocols for Multiple Myeloma Immunotherapy in China. By combining ultra-precise cellular engineering with state-of-the-art diagnostic screening, we ensure precision-targeted delivery for individuals looking to access the next generation of cancer treatment.

From stringent cleanroom laboratory processing to utilizing advanced immunotherapeutic techniques, we guarantee top-tier medical care across our specialized clinical oncology services. Whether you are seeking targeted Leukemia Treatment in China or comprehensive care for refractory blood cancers at our leading facility, Jiahui International Hospital provides a trusted, highly regulated environment where safety, patient monitoring, and global oncology expertise are paramount.

Our Commitment to Cellular Immunotherapy & Oncology:

Targeted Lymphoma Protocols: Advanced, highly individualized Lymphoma CAR-T Therapy in China designed to reprogram your own immune cells to recognize, target, and destroy malignant lymphoma cells.
Next-Gen Myeloma Treatments: Tailored therapeutic programs utilizing breakthrough Multiple Myeloma Immunotherapy in China to target specific myeloma markers and achieve deep, durable remissions.
Elite International Medical Hub: A premier healthcare destination for global patients seeking premium, highly personalized CAR-T care in a private, state-of-the-art, fully accredited international hospital.
Verifiable Global Excellence: Rigorous cell viability and quality checks, strict clinical safety licensing, and internationally certified oncologists focused exclusively on maximizing therapeutic efficacy.

Official Clinic Certifications

Our official medical board licenses and lab certifications underscore our unwavering commitment to patient safety, strict legal compliance, and superior therapeutic delivery.

Jiahui International Hospital CAR-T Cell Therapy Certification

Start Your Journey with a Certified Expert

Discover why discerning international patients choose Jiahui International Hospital as their destination of choice for advanced cellular oncology. Our certified medical team is ready to help you navigate your journey toward healing with elite CAR-T Cell Therapy in Shanghai China.

Book a Certified Consultation

Shanghai, China Destination Overview

Medical Tourism for CAR-T Cell Therapy in Shanghai China

Shanghai has solidified its position as an elite hub for advanced biotechnology, oncology care, and life sciences. Navigating the world of CAR-T Cell Therapy in Shanghai China at Jiahui International Hospital offers patients a unique opportunity to access some of the most advanced cellular immunotherapies available today. As a premier medical destination, this specialized CAR-T Cell Therapy Clinic in China provides an exceptional level of precision and clinical safety that is synonymous with cutting-edge medical innovation. International patients seeking premium oncology solutions benefit from custom-tailored medical pathways designed by leading health specialists.

Whether you are seeking advanced Leukemia Treatment in China, targeted Lymphoma CAR-T Therapy in China, or comprehensive Multiple Myeloma Immunotherapy in China, Jiahui International Hospital combines world-class medical infrastructure with tailored patient care. Choosing professional medical solutions means investing in an evidence-based approach toward cellular healing and long-term remission, backed by the highest quality controls in advanced cancer care.

Access to targeted, state-of-the-art hematological care through highly specialized Leukemia Treatment in China.
Highly customized protocols for cellular extraction and infusion during Lymphoma CAR-T Therapy in China.
Advanced cell processing, genetic modification, and cultivation techniques exclusive to a premier CAR-T Cell Therapy Clinic in China.
Comprehensive patient coordination for international visitors seeking premium CAR-T Cell Therapy in Shanghai China.

How to Get to Shanghai, China?

Located on China's central coast, Shanghai is one of the most affluent, modern, and well-connected global metropolises, making it incredibly accessible for medical travelers arriving for specialized oncology treatments.

By plane: The region is served by two major international hubs—Shanghai Pudong International Airport (PVG) and Shanghai Hongqiao International Airport (SHA)—operating daily direct flights from major international transit hubs across the US, Europe, and Asia, providing a short and comfortable commute to Jiahui International Hospital.
By high-speed rail: Positioned at the center of China's modern rail network, the city is highly accessible from all major provincial capitals, which is highly convenient for domestic and regional patients seeking elite cellular medicine.
By local transit: Dedicated international patient coordinators offer seamless logistics, including secure private medical transfers, professional executive transport, and authorized English-speaking assistance throughout the city.

Essential Travel Tips for CAR-T Medical Tourists

Preparation is key to a rewarding medical experience. To maximize your journey at Jiahui International Hospital, we recommend organizing your travel arrangements and medical history well in advance of visiting our clinical partners.

Medical Records: Provide detailed bone marrow biopsies, PET/CT scans, and recent blood panels to ensure your Multiple Myeloma Immunotherapy in China is precision-mapped.

Virtual Consultation: Connect with Jiahui International Hospital experts online to discuss your treatment history and review cellular extraction schedules.

Modern Lodging: Shanghai boasts world-class international hotels, serviced apartments suited for long-term recovery, and secure, English-friendly residential districts.

Currency: The Chinese Yuan (CNY) is standard. While cash and cards are accepted, setting up digital payment platforms like Alipay or WeChat Pay is highly recommended.

*Note: While Mandarin is the local language, Jiahui International Hospital provides fully bilingual medical staff and dedicated English-speaking patient coordinators to guide you through every step.

Visa and Accommodation Assistance for Patients

China provides a clear and organized entry process for international health travelers. Jiahui International Hospital assists with the necessary clinical documentation to ensure a seamless arrival for your CAR-T Cell Therapy in Shanghai China.

Visa Entry	Most international citizens require a visa to enter China. The hospital provides official medical invitation letters to streamline your application for an 'L' (Tourist) or 'S' (Private Affairs/Medical) visa.
Logistics Support	Patients receive personalized airport pickup, private medical transit to oncology appointments, and direct assistance with corporate rates at nearby partner hotels and long-term recovery suites.
Optimized Recovery	Because CAR-T procedures require a multi-week observation period following cell infusion, we help arrange comfortable, sterile living accommodations close to the hospital campus to support your immune recovery.

Ready to Experience the Future of Medicine?

Discover world-leading CAR-T Cell Therapy in Shanghai China and unmatched clinical excellence at Jiahui International Hospital. Contact us today via PlacidWay to map out your custom oncology recovery journey.

Jiahui International Hospital | CAR-T Cell Therapy in China

Share this listing

Book a consultation with Jiahui International Hospital | CAR-T Cell Therapy in China

No slots available for the week

Share with AI